Application 074834
- Type
- ANDA
- Sponsor
- CHARTWELL MOLECULES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACYCLOVIR | ACYCLOVIR | TABLET;ORAL | 400MG | No | No |
| 002 | ACYCLOVIR | ACYCLOVIR | TABLET;ORAL | 800MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074834-001 | ACYCLOVIR | ACYCLOVIR | 400MG | TABLET / ORAL | 1997-04-24 | ||
| A074834-002 | ACYCLOVIR | ACYCLOVIR | 800MG | TABLET / ORAL | 1997-04-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | 1997-04-24 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | 1997-04-24 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | 1997-04-24 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | 1997-04-24 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | 1997-04-24 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | 1997-04-24 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | 1997-04-24 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | 1997-04-24 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074834-001 | ACYCLOVIR | 400MG | TABLET / ORAL | 1997-04-24 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074834-002 | ACYCLOVIR | 800MG | TABLET / ORAL | 1997-04-24 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 83e82707-85b6-2fea-e053-2991aa0a99ef | 2026-11-04 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | 331fe0bd-6bb2-4337-8faa-d0c82ff54dc7 | 2026-10-30 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | 383b930b-6e9c-4ac9-a078-baac6276f340 | 2026-10-26 | acyclovir ACYCLOVIR | |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 8d4c9317-7475-42ec-a0b0-d43929114369 | 2026-10-12 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | American Health Packaging | 05f42300-2a06-45f1-a9b9-6e5c84ae58ec | 2026-09-29 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | 4a76b92b-f93f-4965-b2b2-4db8f9183306 | 2026-09-18 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | a1086845-ba08-4fb2-81dc-aea9c68bf2c3 | 2026-09-10 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | REMEDYREPACK INC. | c1744e01-0e40-4851-8ffc-c3bf29dd7c2b | 2026-08-31 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 5176c7f9-9076-4797-e054-00144ff8d46c | 2026-08-27 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | e5e99a6b-79a6-7fdb-e053-2a95a90a8563 | 2026-08-26 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 58dc1402-6098-9cb3-e063-6294a90a062b | 2026-08-19 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 50c58161-3944-7367-e063-6394a90a6286 | 2026-08-19 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Cardinal Health 107, LLC | 4cc7d67f-35fa-4238-a581-4810645083cf | 2026-08-13 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| acyclovir | ACYCLOVIR | c | 59007780-d736-4195-a204-7f85a709ed46 | 2026-08-12 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0de2f5c7-9e75-4bdf-9c28-e026cc6694b4 | 2026-07-24 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
| acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 86c43bdf-c5bf-47cd-8dfd-811263825878 | 2026-07-24 | Warnings, Adverse reactions | acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 2026-07-24 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 736679be-469e-4bdb-8e15-b10751c3dd60 | 2026-07-24 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 38547daa-7d2f-4a7b-84d3-6e164984f958 | 2026-07-17 | Warnings, Adverse reactions | Acyclovir ACYCLOVIR |
| ACYCLOVIR | ACYCLOVIR | Major Pharmaceuticals | 9b254eed-8ea1-469b-bf27-f5670cd99e8d | 2026-07-14 | Warnings, Adverse reactions | ACYCLOVIR ACYCLOVIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.